1 report

R& D Progress Research and Development Brief Other Developmental Activities HBN-## - Drug Profile Product Description HBN-## is under development for the treatment of resuscitated post-cardiac arrest, acute ischemic stroke, spinal cord injury, traumatic brain inj

  • Research And Development
  • Therapy
  • United States
  • Company Operations
  • Lixte Biotechnology Holdings, Inc.